Bolt Biotherapeutics (BOLT) Net Margin (2020 - 2026)
Bolt Biotherapeutics' Net Margin was -154400.00% in Q2 2026, down 153925.44 percentage points from -474.56% a year earlier and down 126538.46 percentage points from the prior quarter.
Powered by 
Analysis
Bolt Biotherapeutics (BOLT) Net Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bolt Biotherapeutics' Net Margin was -611.47% through Jun 30, 2026, up 605.55 percentage points year-over-year; for FY2025, it came in at -433.74%, up 387.04 percentage points from FY2024.
- Net Margin has now increased for five consecutive years, with a five-year change of +25855.44 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was -820.78% in FY2024 (+57.80 pp), -878.58% in FY2023 (+659.17 pp), -1537.76% in FY2022 (+6286.93 pp) and -7824.68% in FY2021 (+18464.49 pp).
- The Q2 2026 figure marks the lowest quarterly Net Margin in data going back to Q1 2020.
- Compared with a year earlier, Net Margin was higher in two of the last six quarters, with an average year-over-year change of -30013.41 percentage points.
- The best year-over-year quarter for Net Margin over five years was Q4 2022 (a gain of 3928.64 percentage points); the worst was Q2 2026 (a drop of 153925.44 percentage points).
- Per Business Quant data, BOLT's Net Margin in the three quarters before Q2 2026 was -27861.54% (Q1 2026), -265.24% (Q4 2025) and -329.37% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Bolt Biotherapeutics | 6.88 Mn | 6.88 Mn | - | -154,400.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -154,400.00% |
| Mar 31, 2026 | -27,861.54% |
| Dec 31, 2025 | -265.24% |
| Sep 30, 2025 | -329.37% |
| Jun 30, 2025 | -474.56% |
| Mar 31, 2025 | -903.44% |
| Sep 30, 2024 | -1,330.06% |
| Jun 30, 2024 | -1,662.35% |
| Mar 31, 2024 | -204.99% |
| Dec 31, 2023 | -857.01% |
| Sep 30, 2023 | -643.08% |
| Jun 30, 2023 | -1,260.08% |
| Mar 31, 2023 | -929.90% |
| Dec 31, 2022 | -1,417.22% |
| Sep 30, 2022 | -1,030.26% |
| Jun 30, 2022 | -1,626.99% |
| Mar 31, 2022 | -2,912.42% |
| Dec 31, 2021 | -5,345.87% |
| Sep 30, 2021 | -3,111.04% |
| Jun 30, 2020 | -16,505.97% |
API Access
Bolt Biotherapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();